Some factors related to the outcomes post care for patients with knee osteoarthritis at 108 Military Central Hospital

Nguyen Thi Thuy Nga1, Thanh Hà Lê1,, Phuong Thi Huong1, Dinh Thi Tuyet1, Hoang Viet Ha1, Luong Tuan Anh1, Lai Thi Thu Huyen1
1 108 Military Central Hospital

Main Article Content

Abstract

Objectives: Investigate some factors related to the outcomes after caring for patients with primary knee osteoarthritis at the 108 Military Central Hospital.
Subject and methods: The cross-sectional study was conducted with 245 patients with knee osteoarthritis receiving treatment at the Rheumatology Department - 108 Military Central Hospital from October 2022 to December 2023.
Result: The average age of 245 patients was 62.3 ± 13.0 years. Post-care outcomes classification: Achieve was 80.9%, not achieve was 19.1%. Men are more likely than women to achieve post-care outcomes (OR 95% CI = 2.6; p = 0.012). The accomplishment rate was greater for patients with a disease duration of less than five years than for those with a period of more than 5 years (OR = 1.8; p = 0.037). Patients without comorbidities of gout and lumbar spine degeneration had a higher achievement rate compared to those with these conditions, respectively (OR = 3.4; p = 0.000); (OR = 2.1; p = 0.001). Patients receiving care had better knee flexion and extension range compared to those not receiving care (OR = 9.7; p = 0.000); (OR = 3.8; p = 0.005). Satisfied patients received higher quality care compared to those who were not satisfied (OR = 4.5; p = 0.000).
Conclusion: Through research, it was found that there is a correlation between care outcomes and: gender, duration of illness, comorbidities such as gout and lumbar spine degeneration, range of motion in knee flexion and extension, and patient satisfaction levels. Thus, it can be seen that the monitoring, care, and evaluation work of nurses for patients with knee osteoarthritis constitutes a significant part of the overall treatment outcome, bringing satisfaction to patients, minimizing complications, and improving the quality of life.

Article Details

References

1. Guest JF., Ayoub, N., McIlwraith, T., Uchegbu et al (2015). Health economic burden that wounds impose on the National Health Service in the UK. BMJ Open, 5(12): 1-8.
2. Malone M, Bjarnsholt T, McBain AJ et al (2017). The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. Journal of Wound Care, 26(1): 20-25.
3. Swanson T, Ousey K, Haesler E et al (2022). IWII Wound Infection in Clinical Practice consensus document: 2022 update. Journal of wound care, 31(12): S10-S21.
4. Bradbury S, Fletcher J (2011). Protosan® made easy. Wound, 2(2). Available from http://www.woundsinternational.com
5. Morgan N (2014). How to assess wound exudate. Wound care Advisor, 3(2): 20-21.
6. Frykberg RG, Banks J (2015). Challenges in the Treatment of Chronic Wounds. Adv Wound Care, 4(9): 560-82.
7. Mixrova SS, Burhan A (2024). Comparison of Effectiveness of Hydropobic Cutimed Sorbact Versus Cadexomer Iodine 0.9% on Healing of Diabetic Foot Ulcer: A Randomized Control Trial. J Wound Res Technol, 29;1(1): 28-37.
8. Khalid II, Antoni A, Susanti I (2024). Implementation of Combination of Curcumin Gel and Honey for the Treatment of Diabetic Foot Ulcer: A Pre-Experimental Study. J Wound Res Technol, 30;1(1): 38-45.
9. Deng Q, Huang S, Wen J, Jiao Y, Su X, Shi G et al (2020). PF-127 hydrogel plus sodium ascorbyl phosphate improves Wharton’s jelly mesenchymal stem cell-mediated skin wound healing in mice. Stem Cell Res Ther, 11(1):143.
10. Afonso AC, Oliveira D, Saavedra MJ, Borges A et al (2021). Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies. Int J Mol Sci, 22(15): 8278.
11. Wound Healing and Management Unit, Curtin University (WHAM@Curtin) (2020). Evidence Summary: Polyhexamethylene biguanide hydrochloride for chronic wounds. Wound Practice and Research, 28(4):189-191.
12. Rippon M, Rogers AA, Westgate S, Ousey K (2023). Effectiveness of a polyhexamethylene biguanidecontaining wound cleansing solution using experimental biofilm models. J WOUND CARE, 32(6).